Interpharm Development Private Limited - Due diligence report

A 360° intelligence report on Interpharm Development Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2005-07-08 Ahmedabad, Gujarat Active Unlisted Active Compliant
Share
Connect MCP
ID Interpharm Development Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Interpharm Development Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
66/100
Trust Score
Moderate

Interpharm Development Private Limited is assessed as Moderate with a Trust Score of 66/100. Interpharm Development Private Limited is an active private limited indian non-government company incorporated in 2005, operating in the Financial Services sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 01 Oct 2026 from the latest processed filings. Interpharm Development Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).

Charges position: 3 open (59.50 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited3 48.0 cr
Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: MCA.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
ANUJ GARG 01234567 Director 01/04/2018 6 yrs Approved
PRERNA GARG 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Rbp Holding Llc;
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 6 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Rbp Holding Llc; Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
Operating for 21+ years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 24% in a year.
Compliance score is weak (58/100).
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence67/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment36/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 59.50 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
ANUJ GARG
Director ceased
PRERNA GARG
27 Dec 2023
Charge created
Hdfc Bank Limited - 6.50 cr
04 Oct 2023
Director appointed
PRERNA GARG (Director)
10 Apr 2023
Charge created
Hdfc Bank Limited - 6.50 cr
29 Mar 2023
Charge created
Hdfc Bank Limited - 46.50 cr
01 Dec 2022
Director appointed
ANUJ GARG (Director)
31 Dec 2020
Director ceased
NITIN GARG
Director ceased
DHARAM NAVINKUMAR AGGARWAL
31 Mar 2019
Share transfer (FY 2019)
832930.00000000 shares to VIBRANCE PROJECTS LLP
Share transfer (FY 2019)
746970.00000000 shares to KARYATECH INTERNATIONAL LLP
Share transfer (FY 2019)
75960.00000000 shares to KARYATECH INTERNATIONAL LLP
Share transfer (FY 2019)
1000.00000000 shares to RBP HOLDING LLC
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Lodha & Company U51109WB1986PTC040770 Kolkata, West Bengal, India
Taneja Builders Private Limited U70101DL1986PTC024981 Delhi, Delhi, India
Krishna Sudama Marketing Private Limited U51909WB2012PTC174685 Raghunathpur, West Bengal, India
T T Commercial Co Pvt Ltd U70101WB1995PTC075032 Kolkata, West Bengal, India
Kanwarram Properties Private Limited U70109WB2016PTC218541 Kolkata, West Bengal, India
Adway Aqua Minerale Private Limited U15543TN2009PTC073164 Chennai, Tamil Nadu, India
Anurodh Trading Private Limited U51109WB1997PTC083497 Baruipur, West Bengal, India
Uma Devcon Private Limited U70100MP2011PTC025685 Indore, Madhya Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Interpharm Development Private Limited before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Interpharm Development Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Interpharm Development Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Interpharm Development Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Interpharm Development Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Interpharm Development Private Limited an active company?

Interpharm Development Private Limited has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Interpharm Development Private Limited financially healthy?

Interpharm Development Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Interpharm Development Private Limited?

Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Interpharm Development Private Limited?

The ultimate holding entity is Rbp Holding Llc;. 2 active director(s) are on record.

Does Interpharm Development Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Interpharm Development Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Interpharm Development Private Limited?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.